Authors:
Garland, SM
Sellors, JW
Wikstrom, A
Petersen, CS
Aranda, C
Aractingi, S
Maw, RD
Citation: Sm. Garland et al., Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts - results of an open-label, multicentre Phase IIIB trial, INT J STD A, 12(11), 2001, pp. 722-729
Citation: S. Aractingi, What strategy is best for suspected toxic drug reactions in patients taking several drugs, ANN DER VEN, 128(5), 2001, pp. 693-696
Authors:
Socie, G
Mary, JY
Esperou, H
Robert, DV
Aractingi, S
Ribaud, P
Devergie, A
Toubert, ME
Boudou, P
Cathelinau, B
Gluckman, E
Vexiau, P
Citation: G. Socie et al., Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation, BR J HAEM, 113(1), 2001, pp. 194-201
Authors:
Aractingi, S
Briand, N
Le Danff, C
Viguier, M
Bachelez, H
Michel, L
Dubertret, L
Carosella, ED
Citation: S. Aractingi et al., HLA-G and NK receptor are expressed in psoriatic skin - A possible pathwayfor regulating infiltrating T cells?, AM J PATH, 159(1), 2001, pp. 71-77
Authors:
Wolkenstein, P
Loriot, MA
Aractingi, S
Cabelguenne, A
Beaune, P
Chosidow, O
Citation: P. Wolkenstein et al., Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in AIDS, PHARMACOGEN, 10(9), 2000, pp. 821-828
Authors:
Bachmeyer, C
Monge, M
Dhote, R
Sanguina, M
Aractingi, S
Mougeot-Martin, M
Citation: C. Bachmeyer et al., Eosinophilic fasciitis following idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia and Hashimoto's disease, DERMATOLOGY, 199(3), 1999, pp. 282-282